Inactivation of TP53 and RB1 [12], along with alterations of MYC, NOTCH, and the PI3K/AKT/mTOR pathways, are among the key genetic changes associated with SCLC [13]. This evidence concerns the gene RB1 and small cell lung carcinoma.